WA-KYMETA
10.3.2020 13:02:17 CET | Business Wire | Press release
Kymeta (www.kymetacorp.com )—the communications company making mobile global—announced the commercial availability of its next generation flat panel electronically steered antenna platform, the Kymeta u8. The new u8 terminal paired with Kymeta’s hybrid satellite-cellular connectivity services transforms the purchase and consumption of mobile data with an all-inclusive hardware, connectivity and services monthly subscription starting at $999. The Kymeta u8 is the world’s only commercially available flat panel electronically steered antenna built specifically for mobility and designed for the needs of both military and commercial customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005297/en/
The Kymeta u8 antenna enables complete coverage of the Ku-band with highly reliable electronic beam steering and no moving parts. It is available as an antenna, as a terminal, or in flyaway configurations, and it can be paired with Kymeta’s new satellite and hybrid satellite-cellular connectivity solutions.
Powered by top satellite service and cellular operators throughout the world, Kymeta Connect makes buying hardware, connectivity, network services, and global support as simple and predictable as buying a mobile phone plan. A variety of satellite or satellite-cellular airtime packages are available and provided in partnership with Intelsat and Cubic Telecom, among others. Customers will now have access to easily deployable and dependable mobile connectivity in places where reliable and affordable connectivity has not been available. Kymeta is also working with LEO satellite operators on technology and service collaborations as described in press announcements released during Satellite 2020.
“With our new u8 terminal paired with Kymeta Broadband connectivity and support, we are making mobile global with a fully managed, optimized, and easy to use blended service,” said Walter Berger, President and Chief Operating Officer, Kymeta. “It is a complete solution with an elegant simplicity that will be very attractive to companies who need predictable OPEX pricing for their regional mobile connectivity services. We believe this is an industry tipping point for unlocking new access to the internet in all parts of the world.”
“We look forward to expanding our successful partnership with Kymeta as they add Intelsat’s FlexMove managed service to their communications-on-the-move (COTM) connectivity solutions offerings. Working together, Kymeta and Intelsat are helping people stay connected wherever they need to be, no matter how remote or challenging the location,” said Samer Halawi, Chief Commercial Officer, Intelsat.
Kymeta’s mobile connectivity services will be available in the US, Europe, the Middle East, Asia Pacific, sub-Saharan Africa, and Oceania with services extending to future geographies in the coming months. Initial deployments will include the military, first responders, buses, vehicle fleets, small maritime vessels, ferries, trucks and trains.
Show attendees can sign up for a meeting or live driving demonstration of the Kymeta u8 by emailing marketing@Kymetacorp.com . Additionally, the Kymeta u8 video is live and available to watch at www.kymetacorp.com .
About Kymeta
Kymeta is unlocking the potential of satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for mobile connectivity. The company’s flat-panel satellite antenna, the first of its kind, and Kymeta™ Connect connectivity services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200310005297/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cegid and Silae Join Forces to Create a European Leader in AI-Driven Business Technology9.9.2026 12:32:00 CEST | Press release
Planned Merger Enables Trusted, Fully Integrated Experience Across E-Invoicing, Accounting, Tax, Payroll and HR, Digital Financial Services and Payments for Businesses and their PartnersChristian Pedersen Joins Cegid as CEO to Lead Combined Group Cegid, an AI-driven European leader in cloud business management software for small and medium-sized businesses (SMBs), and accounting professionals, and Silae, France’s leading payroll and human resources platform, today announced their intention to merge. The combination will create a national technology champion and the leading European technology platform for businesses and their partners, helping them grow safely and efficiently with the support of a fully integrated and compliant suite covering their end-to-end financial and administrative needs. Between them, Cegid, following its recent acquisition of Shine, and Silae power the day-to-day accounting, tax, finance and payroll of 2 million end-customers and more than 15,000 chartered acco
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year9.9.2026 12:30:00 CEST | Press release
Notable additional benefit observed with an added reduction in MADRS1 score leading to an average 13-point reduction from baseline at Week 52 with durability extended out to 1 year for participants who were randomized to the 25 mg arm and received an additional doseFor participants randomized to Placebo arm who received first dose of COMP360 25 mg in open-label Part C, data further reinforces that a single 25 mg dose can produce rapid onset, meaningful effect and durabilityFor all participants in Part C who received a 25 mg open-label dose, strong response and remission rates were observed with 40%-45% responders2 and approximately 30% remitters3 across all timepoints 6 weeks post the Part C doseThis 1-year data further supports the belief that, if approved, COMP360 could establish a new standard of care in TRD that can be life-changing for patients − moving beyond daily or frequent administration toward an option that could provide durable benefit with just a few treatments a yearCOMP
New ABB and BCG Report Highlights Growing Role of Direct Current Technologies in Future Power Systems9.9.2026 11:42:00 CEST | Press release
Rapid expansion of AI computing, increasing electrification and rise of renewable energy are driving renewed interest in DC technology as part of future electrical systems Both AC and DC systems have strategically important roles in meeting future electricity demand Establishing common standards and developing DC-specific skills can help accelerate deployment ABB today published a new report, The Strategic Case for Hybrid AC/DC Power: Shaping the Transition to the Next Electrical Architecture, developed in collaboration with Boston Consulting Group (BCG). The report makes the case that direct current (DC) technology is moving from the periphery to the center of industrial, commercial, and digital infrastructure – and that the decisions made by business leaders and policymakers in the next two to three years will determine who shapes that transition and who inherits it. The future of power distribution is not an either-or choice between alternating current (AC) and direct current, but a
Visa and World Bank Group Announce New Risk-Sharing Initiative to Expand Digital Payments and Financial Inclusion in Emerging Markets9.9.2026 11:00:00 CEST | Press release
Visa (NYSE: V), a global leader in digital payments, and the International Finance Corporation (IFC), a member of the World Bank Group focused on the private sector, are partnering on an innovative risk-sharing initiative designed to help expand financial inclusion by increasing access to digital financial services in emerging markets. Under the agreement, IFC will share credit settlement risk for Visa transactions associated with enrolled financial institutions, enabling these institutions to connect more underbanked consumers and small businesses to digital payments. The facility is expected to support approximately $200 million in risk sharing over five years, with an initial focus on 14 countries in Latin America and the Caribbean and reach approximately 50 financial institutions with below-investment grade ratings. Together, Visa and IFC aim to help financial institutions enable millions more people and small businesses to save, spend, borrow, grow, and participate more fully in t
Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities9.9.2026 11:00:00 CEST | Press release
HIGHLIGHTS H1 2026 revenues of €1.89 billion, up +3.6% at CER versus H1 2025, driven by growth in the inhaled triple therapy portfolio and strong momentum in the rare diseases therapeutic area Continued investment in innovation with €426 million invested in R&D (22.5% of sales) Completed strategic investment for treatment of hereditary angioedema (HAE) with acquisition of KalVista Pharmaceuticals EBITDA continues to remain close to 30%, reflecting continued strong profitability and disciplined resource allocation Recent Economic Footprint study highlights Chiesi's contribution to economic development, supporting 56,488 jobs globally, generating €6.0 billion in GDP impact and €2.0 billion in taxes and public revenues worldwide Chiesi Group ("Chiesi"), an international research-focused biopharmaceutical company and certified B Corp, today announced its financial results for the six months ended 30 June 2026 ("H1 2026"). Performance across therapeutic areas and regions Chiesi reported rev
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom